ANI Pharmaceuticals, Inc. (ANIP) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "ANIP"
      ],
      "issuer_cik": "0001023024",
      "owner_cik": "0001822629",
      "accession_number": "0001822629-26-000018",
      "form_type": "4",
      "filing_date": "2026-10-16",
      "period_of_report": "2026-10-15",
      "issuer_name": "ANI PHARMACEUTICALS INC",
      "issuer_trading_symbol": "ANIP",
      "owner_name": "Lalwani Nikhil",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "PRESIDENT & CEO",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-15",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 5400,
      "transaction_price_per_share": 71.89,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 333689,
      "transaction_value": 388206,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2026."
        },
        {
          "id": "F2",
          "description": "The shares were sold in multiple trades at prices ranging from $71.08 to $72.56. The price reported above reflects the weighted average sales price."
        }
      ]
    },
    {
      "tickers": [
        "ANIP"
      ],
      "issuer_cik": "0001023024",
      "owner_cik": "0001938861",
      "accession_number": "0001938861-26-000028",
      "form_type": "4",
      "filing_date": "2026-10-13",
      "period_of_report": "2026-10-13",
      "issuer_name": "ANI PHARMACEUTICALS INC",
      "issuer_trading_symbol": "ANIP",
      "owner_name": "Cook Meredith",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "SR. VP, GENERAL COUNSEL & SEC.",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-13",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 500,
      "transaction_price_per_share": 73.59,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 73424,
      "transaction_value": 36795,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.